{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:13:21Z","timestamp":1758629601716},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Regional Development Fund-ERDF","award":["380379"],"award-info":[{"award-number":["380379"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.psychres.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T02:31:16Z","timestamp":1499049076000},"page":"378-383","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Changes in the cytokine profile in first-episode, drug-na\u00efve patients with psychosis after short-term antipsychotic treatment"],"prefix":"10.1016","volume":"256","author":[{"given":"Petros","family":"Petrikis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros T.","family":"Tzallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki A.","family":"Boumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra T.","family":"Archimandriti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Zambetas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Tsoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Skapinakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venetsanos","family":"Mavreas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.07.002_bib1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psyneuen.2015.03.003","article-title":"Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia","volume":"56","author":"Borovcanin","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0278-5846(01)00221-4","article-title":"Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study","volume":"26","author":"Cazzullo","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2006.08.005","article-title":"Interleukin-12 plasma levels in drug-naive patients with a first episode of psychosis: effects of antipsychotic drugs","volume":"158","author":"Crespo-Facorro","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","article-title":"Cytokines in schizophrenia and the effects of antipsychotic drugs","volume":"20","author":"Drzyzga","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psychres.2017.07.002_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","article-title":"Dyslipidemia and inflammation: an evolutionary conserved mechanism","volume":"24","author":"Esteve","year":"2005","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.psychres.2017.07.002_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JCP.0b013e31820fcea3","article-title":"Metabolic effects of olanzapine in patients with newly diagnosed psychosis","volume":"31","author":"Fernandez-Egea","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.07.002_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2017.07.002_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2015.08.027","article-title":"Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index","volume":"169","author":"Haring","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2007.01.019","article-title":"Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro","volume":"92","author":"Kato","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib13","series-title":"Immunopharmacology","author":"Khan","year":"2008"},{"key":"10.1016\/j.psychres.2017.07.002_bib14","first-page":"65237","author":"Klabusay","year":"2006","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.psychres.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2014.04.049","article-title":"Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine","volume":"218","author":"Klemettila","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia","volume":"50","author":"Kowalski","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbi.2011.05.014","article-title":"Anti-inflammatory signaling in schizophrenia","volume":"25","author":"Meyer","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psychres.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.002_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02922260","article-title":"Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia","volume":"247","author":"M\u00fcller","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2017.07.002_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","article-title":"The immune system and schizophrenia. An integrative view","volume":"917","author":"M\u00fcller","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.psychres.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug-na\u00efve first-episode psychosis","volume":"164","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cyto.2014.11.003","article-title":"Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication","volume":"73","author":"O'Connell","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.psychres.2017.07.002_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpsychores.2015.06.011","article-title":"Cytokine profile in drug-naive, first episode patients with psychosis","volume":"79","author":"Petrikis","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.002_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000067807","article-title":"The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro","volume":"46","author":"Rudolf","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2017.07.002_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbi.2015.06.004","article-title":"Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study","volume":"49","author":"Russell","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psychres.2017.07.002_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psychres.2004.04.012","article-title":"Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients","volume":"134","author":"Sirota","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(99)00116-4","article-title":"Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist","volume":"42","author":"Song","year":"2000","journal-title":"Shizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2015.10.038","article-title":"Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment- resistant schizophrenia","volume":"169","author":"Tan","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2014.07.025","article-title":"Neuroimmune biomarkers in schizophrenia","volume":"176","author":"Tomasik","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4236\/abb.2012.324072","article-title":"In vivo immunomodulatory effects of antipsychotics on inflammatory mediators: a review","volume":"3","author":"Tourjman","year":"2012","journal-title":"Adv. Biosci. Biotechnol."},{"key":"10.1016\/j.psychres.2017.07.002_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.07.002_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","article-title":"Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment","volume":"154","author":"de Witte","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116317309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116317309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T05:46:07Z","timestamp":1621057567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116317309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":37,"alternative-id":["S0165178116317309"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.07.002","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the cytokine profile in first-episode, drug-na\u00efve patients with psychosis after short-term antipsychotic treatment","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}